Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?
18 F-FDG PET/CT, 18F-fluorodeoxyglucose by positron emission tomography/computed tomography
CBD, Chronic beryllium disease
DLCO, diffusing capacity of the lung for carbon monoxide
EDXA, Energy-dispersive X-ray spectroscopy analysis
FVC, Forced Vital Capacity
HRCT, High-resolution computed tomography
Infliximab
LPT, Lymphocyte proliferation test
Sarcoidosis
Sarcoidosis phenotypes
Silica
Silicosis
Journal
Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
02
2019
revised:
08
07
2019
accepted:
08
07
2019
entrez:
26
7
2019
pubmed:
26
7
2019
medline:
26
7
2019
Statut:
epublish
Résumé
A diagnosis of silicosis is made on the basis of exposure and typical radiological findings, according to the ILO's International Classification of Radiographs of Pneumoconiosis. Radiological patterns of silicosis can, however, resemble sarcoidosis. Sarcoidosis is a multi-systemic disorder of unknown etiology, although a role for initiating inorganic triggers such as metals or silica has been suggested. In this case report, we illustrate a patient previously diagnosed with silicosis based on exposure and radiological features, progressive under immunosuppressive treatment. In view of these findings, an open lung biopsy was performed and revealed sarcoidosis. The patient was effectively treated with infliximab. Further analysis showed the presence of silica in the granulomas. Sensitization to silica was also demonstrated, suggesting an association between silica exposure and sarcoidosis in this patient.
Identifiants
pubmed: 31341766
doi: 10.1016/j.rmcr.2019.100906
pii: S2213-0071(19)30077-2
pii: 100906
pmc: PMC6630015
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100906Références
Lancet. 2009 Jun 6;373(9679):1943-4
pubmed: 19501734
Am J Respir Crit Care Med. 2006 Oct 1;174(7):795-802
pubmed: 16840744
Eur Respir J. 2006 Jun;27(6):1190-5
pubmed: 16540500
Med Pr. 2016 Dec 22;67(6):833-837
pubmed: 28005090
Occup Environ Med. 1998 Oct;55(10):657-60
pubmed: 9930085
BMJ Open. 2017 Jul 20;7(7):e016839
pubmed: 28729325
Dis Mon. 2007 Aug;53(8):394-416
pubmed: 17976433
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Jun;31(6):406-9
pubmed: 19031797
Acta Biomed. 2005;76 Suppl 2:11-4
pubmed: 16350545
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun;20(2):104-9
pubmed: 12870719
Eur Respir J. 1998 Sep;12(3):750
pubmed: 9762810
Respir Med. 2018 May;138S:S7-S13
pubmed: 29496351
Toxicol In Vitro. 1994 Oct;8(5):991-1000
pubmed: 20693060
Am J Respir Crit Care Med. 2014 Nov 15;190(10):e34-59
pubmed: 25398119
Eur Respir J. 2012 Jan;39(1):221-2
pubmed: 22210816
Eur Respir J. 2015 Jul;46(1):175-85
pubmed: 25929955
Respir Med. 2012 Dec;106(12):1810-3
pubmed: 22974830